BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17141460)

  • 1. Evaluation of lateral flow assays for the detection of botulinum neurotoxin type A and their application in laboratory diagnosis of botulism.
    Gessler F; Pagel-Wieder S; Avondet MA; Böhnel H
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):243-9. PubMed ID: 17141460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and selective detection of botulinum neurotoxin serotype-A and -B with a single immunochromatographic test strip.
    Ching KH; Lin A; McGarvey JA; Stanker LH; Hnasko R
    J Immunol Methods; 2012 Jun; 380(1-2):23-9. PubMed ID: 22504369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a new functional dual coating (FDC) assay to measure low toxin levels in serum and food samples following an outbreak of human botulism.
    Jones RGA; Marks JD
    J Med Microbiol; 2013 Jun; 62(Pt 6):828-835. PubMed ID: 23518650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommended Immunological Strategies to Screen for Botulinum Neurotoxin-Containing Samples.
    Simon S; Fiebig U; Liu Y; Tierney R; Dano J; Worbs S; Endermann T; Nevers MC; Volland H; Sesardic D; Dorner MB
    Toxins (Basel); 2015 Nov; 7(12):5011-34. PubMed ID: 26703727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection.
    Rivera VR; Gamez FJ; Keener WK; White JA; Poli MA
    Anal Biochem; 2006 Jun; 353(2):248-56. PubMed ID: 16620745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Clostridium botulinum types C and D toxin by ELISA.
    Thomas RJ
    Aust Vet J; 1991 Mar; 68(3):111-3. PubMed ID: 2043084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid detection of botulinum neurotoxins A, B, E, and F by optical immunoassay.
    Ganapathy R; Padmanabhan S; Eric YP; Moochhala S; Lionel LK; Ponnampalam G
    Front Biosci; 2008 May; 13():5432-40. PubMed ID: 18508597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and comparison of two immunoassay formats for rapid detection of botulinum neurotoxin type A.
    Attrée O; Guglielmo-Viret V; Gros V; Thullier P
    J Immunol Methods; 2007 Aug; 325(1-2):78-87. PubMed ID: 17659299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulism in Brazil, 2000-2008: epidemiology, clinical findings and laboratorial diagnosis.
    Rowlands RE; Ristori CA; Lopes GI; Paula AM; Sakuma H; Grigaliunas R; Lopreato Filho R; Gelli DS; Eduardo MB; Jakabi M
    Rev Inst Med Trop Sao Paulo; 2010; 52(4):183-6. PubMed ID: 21748224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.
    Centurioni DA; Egan CT; Perry MJ
    J Clin Microbiol; 2022 Apr; 60(4):e0013920. PubMed ID: 34586891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A label-free biosensor assay for botulinum neurotoxin B in food and human serum.
    Ferracci G; Marconi S; Mazuet C; Jover E; Blanchard MP; Seagar M; Popoff M; Lévêque C
    Anal Biochem; 2011 Mar; 410(2):281-8. PubMed ID: 21134347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tonsils--place of botulinum toxin production: results of routine laboratory diagnosis in farm animals.
    Böhnel H; Wagner C; Gessler F
    Vet Microbiol; 2008 Aug; 130(3-4):403-9. PubMed ID: 18387756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.
    Woodruff BA; Griffin PM; McCroskey LM; Smart JF; Wainwright RB; Bryant RG; Hutwagner LC; Hatheway CL
    J Infect Dis; 1992 Dec; 166(6):1281-6. PubMed ID: 1431246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in laboratory diagnosis of wound botulism and tetanus among injecting illicit-drug users by use of real-time PCR assays for neurotoxin gene fragments.
    Akbulut D; Grant KA; McLauchlin J
    J Clin Microbiol; 2005 Sep; 43(9):4342-8. PubMed ID: 16145075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory procedures for cases of suspected infant botulism.
    Hatheway CL
    Rev Infect Dis; 1979; 1(4):647-51. PubMed ID: 551514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.
    Szílagyi M; Rivera VR; Neal D; Merrill GA; Poli MA
    Toxicon; 2000 Mar; 38(3):381-9. PubMed ID: 10669027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Poisoning with botulinum neurotoxin--diagnostic difficulties].
    Grygorczuk S; Pancewicz S; Kondrusik M; Zajkowska J
    Pol Merkur Lekarski; 2000 Aug; 9(50):572-4. PubMed ID: 11081329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative real-time PCR for detection of the neurotoxin gene of Clostridium botulinum type B in equine and bovine samples.
    Johnson AL; Sweeney RW; McAdams SC; Whitlock RH
    Vet J; 2012 Oct; 194(1):118-20. PubMed ID: 22537645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A.
    Fota-Markowska H; Mitosek-Szewczyk K; Hasiec T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):231-2. PubMed ID: 17305749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.